Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AOSLO Imaging for the Study of Cellular Alterations in Retinal Neurodegeneration

NCT07725055 is registered in ClinicalTrials.gov with Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts as lead sponsor.

NCT NCT07725055
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07725055 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AOSLO Imaging for the Study of Cellular Alterations in Retinal Neurodegeneration
Lead sponsor
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
April 30, 2030
Enrollment
260 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma associated with other ocular disorders, retina disorder